Adverse events · participants with chronic prostatitis/chronic pelvic pain syndrome
Traditional Chinese Medicine showed no clear difference in adverse events compared with placebo or usual care (low certainty).
1 finding from 1 review
Sexual dysfunction ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome
1 finding from 1 review
Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Anxiety and depression: anxiety · participants with chronic prostatitis/chronic pelvic pain syndrome
1 finding from 1 review
Depressive symptoms · participants with chronic prostatitis/chronic pelvic pain syndrome
1 finding from 1 review
Sexual dysfunction ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome
1 finding from 1 review
Quality of life · participants with chronic prostatitis/chronic pelvic pain syndrome
1 finding from 1 review
Anxiety and depression · participants with chronic prostatitis/chronic pelvic pain syndrome
1 finding from 1 review
Prostatitis symptoms · participants with chronic prostatitis/chronic pelvic pain syndrome
1 finding from 1 review
Prostatitis symptoms: 'responders' Number of participants with a 25% decrease in NIH‐CPSI scores · participants with chronic prostatitis/chronic pelvic pain syndrome
5‐alpha reductase inhibitors showed no clear difference in prostatitis symptoms: 'responders' Number of participants with a 25%… compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Comparison: outcome · participants at risk of high altitude illness
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Iron supplementation versus placebo: risk of AMS · participants at risk of high altitude illness
The intervention showed no clear difference in iron supplementation versus placebo: risk of AMS (low certainty).
1 finding from 1 review
Intervention not reported
Rhodiola crenulata versus placebo: risk of AMS · participants at risk of high altitude illness
The intervention showed no clear difference in rhodiola crenulata versus placebo: risk of AMS (low certainty).
1 finding from 1 review
Intervention not reported
Comparison: outcome · participants at risk of high altitude illness
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Ginkgo biloba versus acetazolamide: risk of AMS · participants at risk of high altitude illness
The intervention may leads to lower ginkgo biloba versus acetazolamide: risk of AMS (low certainty).
1 finding from 1 review
Intervention not reported
Acetazolamide + ginkgo biloba versus ginkgo biloba: risk of AMS · participants at risk of high altitude illness
The intervention may leads to lower acetazolamide + ginkgo biloba versus ginkgo biloba: risk of AMS (low certainty).
1 finding from 1 review
Intervention not reported
Acetazolamide + ginkgo biloba versus acetazolamide: risk of AMS · participants at risk of high altitude illness
The intervention showed no clear difference in acetazolamide + ginkgo biloba versus acetazolamide: risk of AMS (low certainty).
1 finding from 1 review
Intervention not reported
Acetazolamide versus medroxyprogesterone: risk of AMS · participants at risk of high altitude illness
The intervention showed no clear difference in acetazolamide versus medroxyprogesterone: risk of AMS (low certainty).
1 finding from 1 review
Intervention not reported
Acetazolamide + medroxyprogesterone versus medroxyprogesterone: risk of AMS · participants at risk of high altitude illness
The intervention showed no clear difference in acetazolamide + medroxyprogesterone versus medroxyprogesterone: risk… (low certainty).
1 finding from 1 review
Intervention not reported
Acetazolamide + medroxyprogesterone versus acetazolamide: risk of AMS · participants at risk of high altitude illness
The intervention showed no clear difference in acetazolamide + medroxyprogesterone versus acetazolamide: risk of AMS (low certainty).
1 finding from 1 review